<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-ijms-22-00962">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Choi</surname>
    <given-names>H.R.</given-names>
   </name>
   <name>
    <surname>Nam</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>H.S.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>Y.S.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Date</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Toyama</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>K.C.</given-names>
   </name>
  </person-group>
  <article-title>Phlorizin, an active ingredient of 
   <italic>Eleutherococcus senticosus</italic>, increases proliferative potential of keratinocytes with inhibition of MiR135b and increased expression of type IV collagen
  </article-title>
  <source>Oxidative Med. Cell. Longev.</source>
  <year>2016</year>
  <volume>2016</volume>
  <fpage>3859721</fpage>
  <pub-id pub-id-type="doi">10.1155/2016/3859721</pub-id>
 </element-citation>
</ref>
